Andrea Méndez García is a Biotechnology Engineer (B.Sc.) from Tecnológo de Monterrey. She has experience working in population' genetics, nanobiotechnology applied in inorganic and organic nanoparticle-based cancer treatments, unicellular eukaryotic transformation, plant cloning, and cytotoxicity assays in various cancer cell lines. She has written and published several original and review articles about nanoparticle-based therapeutics, ncRNA expression in animal and plant models, and population genetics. She also performed a research internship at the Wyss Institute at Harvard Medical School about the design of lipid-based nanoparticles for brain delivery.